Los Angeles Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,877
Closed -$29.2K 1218
2023
Q2
$29.2K Buy
11,877
+127
+1% +$312 ﹤0.01% 1146
2023
Q1
$26.6K Sell
11,750
-901
-7% -$2.04K ﹤0.01% 1150
2022
Q4
$44.2K Buy
12,651
+6,600
+109% +$23K ﹤0.01% 1179
2022
Q3
$224K Buy
+6,051
New +$224K ﹤0.01% 1154